Form 4: Prime Medicine CFO Allan Reine Acquires 75,000 Shares Following Performance Milestone Achievement

Prime Medicine's CFO, Allan Reine, acquired 75,000 shares of company stock on May 8, 2025, following the achievement of a performance milestone related to a previously granted stock option.

Summary

• On May 8, 2025, Allan Reine, the Chief Financial Officer of Prime Medicine, Inc., acquired 75,000 shares of common stock due to the vesting of a portion of a stock option.
• The vesting was triggered by the achievement of a performance milestone condition determined by the company's board of directors.
• The stock option, initially granted on January 17, 2024, allows Reine to purchase shares at an exercise price of $6.80.
• Following the transaction, Reine directly owns 850,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The vesting of shares due to a performance milestone suggests the company is making progress, which is generally viewed favorably. The CFO's increased stake aligns his interests with shareholders.

Positives

• The achievement of a performance milestone suggests positive progress for Prime Medicine.
• The vesting of shares for the CFO aligns his interests with those of the shareholders.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The vesting of shares could be viewed positively by shareholders as it aligns management's interests with the company's performance.

Key Dates

Keywords

Prime Medicine, Allan Reine, CFO, stock option, performance milestone, Form 4, beneficial ownership, PRME